Uncategorized – Page 265

BMS Realigns Workforce Post-Mergers and Acquisitions: A Strategic Move Affecting 2,200 Employees

1 year ago talkbio0Tagged Acquisitions, Burning Mouth Syndrome, mergers, strategic, Workers

BMS, layoffs, mergers and acquisitions, workforce realignment, strategic move, 2, 200 employees

GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation

1 year ago talkbio0Tagged BioNTech, COVID19 (disease), infringement, Intellectual Property, Legal patent, Pfizer, SmithKline Beecham, Vaccines

GSK, Pfizer, BioNTech, COVID-19, patent infringement, vaccine, lawsuit, intellectual property

Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination

1 year ago talkbio0Tagged adulteration, blood pressure medication, Dosage Forms, Endometriosis, Expiration, function, hydrochlorothiazide, Mental Recall, mg/12.5, Tablet Dosage Form

Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022

Merck & Co.’s Q1 Success Driven by Keytruda, Ups 2024 Outlook

1 year ago talkbio0Tagged Cancer Therapeutic Procedure, Co., earnings, Keytruda, Projections and Predictions

Merck & Co., Q1 earnings, Keytruda, pharmaceuticals, cancer treatment, 2024 forecast

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

1 year ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, development aspects, Gene Modification, Genetic Research, Health care facility, Mammoth Biosciences, Partnership, Regeneron

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.